Table 2 Median years of education and median difference in education (by quantile regression) comparing no hormone therapy use to systemic and local hormone therapy shown separately for each age group in the singleton population.
From: Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study
Median (IQR) | Median difference (95% CI) | |||
|---|---|---|---|---|
2000 | 2005 | 2000 | 2005 | |
Age 51–55 | ||||
No HT | 13 (8–13) | 0 (ref) | ||
Systemic HT | 13 (8–13) | 0 (− 0.3; 0.3) | ||
Local HT | 13 (8–13) | 0 (− 0.6; 0.6) | ||
Age 56–60 | ||||
No HT | 11 (7–13) | 13 (8–13) | 0 (ref) | 0 (ref) |
Systemic HT | 12 (7–13) | 13 (8–13) | 1.5 (0.8; 2.2) | 0 (− 0.3; 0.3) |
Local HT | 12 (7–13) | 13 (9–13) | 1.5 (0.3; 2.7) | 0 (− 0.3; 0.3) |
Age 61–65 | ||||
No HT | 8 (7–13) | 11 (7–13) | 0 (ref) | 0 (ref) |
Systemic HT | 11 (7–13) | 12 (7–13) | 3 (2.1; 3.9) | 1 (0.3; 1.7) |
Local HT | 10 (7–13) | 13 (7–13) | 2 (0.7; 3.3) | 2 (1.3; 2.7) |
Age 66–70 | ||||
No HT | 7 (7–13) | 9 (7–13) | 0 (ref) | 0 (ref) |
Systemic HT | 9 (7–13) | 12 (7–13) | 2 (1.5; 2.5) | 3 (1.7; 4.3) |
Local HT | 10 (7–13) | 10 (7–13) | 3 (2.3 ; 3.7) | 1 (− 0.1; 2.1) |
Age 71–75 | ||||
No HT | 7 (7–13) | 7 (7–13) | 0 (ref) | 0 (ref) |
Systemic HT | 9 (7–13) | 9 (7–13) | 2 (1.9; 2.1) | 2 (1.3; 2.7) |
Local HT | 7 (7–13) | 9 (7–13) | 0 (− 0.1; 0.1) | 2 (1.5; 2.5) |
Age 76–80 | ||||
No HT | 7 (7–12) | 7 (7–13) | 0 (ref) | 0 (ref) |
Systemic HT | 9 (7–13) | 9 (7–13) | 2 (1.9; 2.1) | 2 (1.8; 2.2) |
Local HT | 7 (7–12) | 7 (7–13) | 0 (− 0.1; 0.1) | 0 (− 0.1; 0.1) |
Age 81–85 | ||||
No HT | 7 (7–13) | 0 (ref) | ||
Systemic HT | 10 (7–13) | 3 (2.9; 3.1) | ||
Local HT | 7 (7–13) | 0 (− 0.1; 0.1) | ||
